Dr. Konstantinos Tziomalos

Aristotle University of Thessaloniki, Greece

Assistant Professor

Email: ktziomalos@yahoo.com

Qualifications

2007 Ph.D., Aristotle University of Thessaloniki, Greece

2003 M.Sc., Aristotle University of Thessaloniki, Greece

1998 B.Sc., Aristotle University of Thessaloniki, Greece

Publications (Selected)

1. Papanikolaou, P., Theodoridis, X., Papaemmanouil, A., Papageorgiou, N. N., Tsankof, A., Haidich, A. B., ... & Tziomalos, K. (2025). Enteral Nutrition Versus a Combination of Enteral and Parenteral Nutrition in Critically Ill Adult Patients in the Intensive Care Unit: An Overview of Systematic Reviews and Meta-Analysis. Journal of Clinical Medicine, 14(3), 991.
2. Anagnostis, P., Rizos, C. V., Liamis, G., Rallidis, L., Skoumas, I., Kolovou, G., ... & Liberopoulos, E. (2025). Exploring the correlation between triglyceride levels and atherosclerotic cardiovascular disease prevalence in adults with familial hypercholesterolemia: Insights from a cross-sectional analysis in the HELLAS-FH registry. Journal of Clinical Lipidology.
3. Boutari, C., Rizos, C. V., Liamis, G., Skoumas, I., Rallidis, L., Garoufi, A., ... & Mantzoros, C. S. (2024). The effect of lipid-lowering treatment on indices of MASLD in familial hypercholesterolemia patients. Clinical Nutrition, 43(12), 84-91.
4. Elshorbagy, A., Lyons, A. R., Vallejo-Vaz, A. J., Stevens, C. A., Dharmayat, K. I., Brandts, J., ... & Yu, W. (2024). Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study. The Lancet Diabetes & Endocrinology, 12(11), 811-823.
5. Deanfield, J., Verma, S., Scirica, B. M., Kahn, S. E., Emerson, S. S., Ryan, D., ... & Coetzee, K. (2024). Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial. The Lancet, 404(10454), 773-786.
6. Psyllaki, A., & Tziomalos, K. (2024). New perspectives in the management of diabetic nephropathy. World Journal of Diabetes, 15(6), 1086.
7. Rallidis, L. S., Rizos, C. V., Papathanasiou, K. A., Liamis, G., Skoumas, I., Garoufi, A., ... & Liberopoulos, E. (2024). Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry. Journal of Cardiovascular Medicine, 25(5), 370-378.
8. Barkas, F., Rizos, C. V., Liamis, G., Skoumas, I., Garoufi, A., Rallidis, L., ... & Liberopoulos, E. (2024). Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: an analysis from HELLAS-FH registry. Journal of Clinical Lipidology, 18(3), e394-e402.
9. Katsiki, N., Filippatos, T., Vlachopoulos, C., Panagiotakos, D., Milionis, H., Tselepis, A., ... & Liberopoulos, E. (2024). Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias-2023. Atherosclerosis Plus, 55, 74-92.
10. Dharmayat, K. I., Vallejo-Vaz, A. J., Stevens, C. A., Brandts, J. M., Lyons, A. R., Groselj, U., ... & Ferrieres, D. (2024). Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study. The Lancet, 403(10421), 55-66.
11. Kourtidou, C., & Tziomalos, K. (2023). Epidemiology and risk factors for stroke in chronic kidney disease: A narrative review. Biomedicines, 11(9), 2398.
12. Kourtidou, C., & Tziomalos, K. (2023). The role of histone modifications in the pathogenesis of diabetic kidney disease. International Journal of Molecular Sciences, 24(6), 6007.
13. Kotsos, D., & Tziomalos, K. (2023). Microsomal prostaglandin E synthase-1 and-2: emerging targets in non-alcoholic fatty liver disease. International Journal of Molecular Sciences, 24(3), 3049.
14. Polychronopoulos, G., Papagiannis, A., & Tziomalos, K. (2023). Strategies for lowering lipoprotein (a): a spotlight on novel pharmacological treatments. Expert Review of Clinical Pharmacology, 16(2), 97-99.
15. Mougakou, E., Mastrogianni, E., Kyziroglou, M., & Tziomalos, K. (2023). The role of novel antibiotics in the management of diabetic foot infection. Diabetes Therapy, 14(2), 251-263.
16. Boutari, C., Rizos, C. V., Doumas, M., Liamis, G., Skoumas, I., Rallidis, L., ... & Liberopoulos, E. (2022). Prevalence of diabetes and its association with atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH). Pharmaceuticals, 16(1), 44.

Profile Details

https://orcid.org/0000-0002-3172-1594

https://www.med.auth.gr/en/users/ktziomal

https://scholar.google.com.hk/citations?user=zu_xLMAAAAAJ&hl=en

https://www.researchgate.net/profile/Konstantinos-Tziomalos